Elevance Health (ELV) Cost of Revenue (2009 - 2026)

Elevance Health (ELV) has 18 years of Cost of Revenue data on file, last reported at $35.6 billion in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $35.6 billion, up 614.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $84.6 billion (up 242.32% YoY), and the FY2025 annual result was $21.2 billion, up 7.23% from the prior year.
• Cost of Revenue grew to $35.6 billion in Q1 2026 per ELV's latest filing, from $5.5 billion in the prior quarter.
• Over five years, Cost of Revenue peaked at $111.9 billion in Q4 2023 and troughed at -$74.3 billion in Q4 2024.
• A 5-year average of $14.3 billion and a median of $5.1 billion in 2024 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2023 and 2024: Cost of Revenue jumped 2968.4% in 2023, then sank 166.43% in 2024.
• A 5-year view of Cost of Revenue shows it stood at $3.6 billion in 2022, then jumped by 2968.4% to $111.9 billion in 2023, then slumped by 166.43% to -$74.3 billion in 2024, then soared by 107.43% to $5.5 billion in 2025, then surged by 544.97% to $35.6 billion in 2026.
• Business Quant data shows ELV's Cost of Revenue at $35.6 billion in Q1 2026, $5.5 billion in Q4 2025, and $38.1 billion in Q3 2025.